Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Actinium Pharmaceuticals (ATNM) Equity Ratio (2021 - 2025)

Actinium Pharmaceuticals (ATNM) has disclosed Equity Ratio for 8 consecutive years, with 0.15 as the latest value for Q4 2025.

  • Quarterly Equity Ratio changed N/A to 0.15 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.15 through Dec 2025, changed N/A year-over-year, with the annual reading at 0.15 for FY2025, N/A changed from the prior year.
  • Equity Ratio for Q4 2025 was 0.15 at Actinium Pharmaceuticals, down from 0.25 in the prior quarter.
  • The five-year high for Equity Ratio was 0.95 in Q2 2021, with the low at 0.15 in Q4 2025.
  • Average Equity Ratio over 5 years is 0.58, with a median of 0.54 recorded in 2023.
  • The sharpest move saw Equity Ratio dropped 1.99% in 2022, then plummeted 47.24% in 2025.
  • Over 5 years, Equity Ratio stood at 0.91 in 2021, then tumbled by 36.36% to 0.58 in 2022, then decreased by 23.28% to 0.45 in 2023, then grew by 4.17% to 0.47 in 2024, then plummeted by 67.48% to 0.15 in 2025.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 0.15, 0.25, and 0.3 for Q4 2025, Q3 2025, and Q2 2025 respectively.